Veerhealth Care Ltd Stock Price Today (NSE: VEERHEALTH)
Fundamental Score
Veerhealth Care Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Veerhealth Care Ltd share price today is ₹43.72, up +3.95% on NSE/BSE as of 3 August 2026. Veerhealth Care Ltd (VEERHEALTH) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹81.07 (Cr). The 52-week high for VEERHEALTH share price is ₹42.21 and the 52-week low is ₹16.75. At a P/E ratio of 121.00x, VEERHEALTH is currently trading above its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 2.97% and a debt-to-equity ratio of 0.20.
Veerhealth Care Ltd Share Price Chart — NSE/BSE Historical Performance
Veerhealth Care Ltd share price chart: 29.90% return over the past month. 52-week high ₹42.21, 52-week low ₹16.75.
Veerhealth Care Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹42.20 | ₹42.20 | ₹41.75 | ₹42.19 | 32.16K (Cr) | |
| ₹41.80 | ₹42.20 | ₹41.50 | ₹42.19 | 19.56K (Cr) | |
| ₹42.20 | ₹42.20 | ₹41.50 | ₹42.08 | 95.45K (Cr) | |
| ₹41.50 | ₹42.21 | ₹41.13 | ₹42.16 | 3.07L (Cr) | |
| ₹41.00 | ₹41.25 | ₹41.00 | ₹41.16 | 74.23K (Cr) | |
| ₹40.80 | ₹41.50 | ₹40.40 | ₹41.07 | 49.44K (Cr) | |
| ₹40.50 | ₹40.95 | ₹40.00 | ₹40.80 | 1.07L (Cr) | |
| ₹40.60 | ₹40.81 | ₹40.60 | ₹40.70 | 83.17K (Cr) | |
| ₹38.85 | ₹39.01 | ₹38.50 | ₹38.96 | 60.21K (Cr) | |
| ₹38.76 | ₹38.86 | ₹38.00 | ₹38.82 | 1.57L (Cr) |
Veerhealth Care Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹32.52 | ₹42.21 | ₹32.01 | ₹42.19 | +29.74% | |
| ₹23.62 | ₹32.50 | ₹23.00 | ₹32.48 | +37.51% | |
| ₹20.63 | ₹24.01 | ₹20.16 | ₹24.00 | +16.34% | |
| ₹20.10 | ₹21.45 | ₹18.40 | ₹20.63 | +2.64% | |
| ₹18.55 | ₹20.61 | ₹18.26 | ₹20.14 | +8.57% | |
| ₹18.90 | ₹20.39 | ₹17.10 | ₹19.70 | +4.23% | |
| ₹19.52 | ₹19.90 | ₹17.00 | ₹18.20 | -6.76% | |
| ₹19.45 | ₹20.23 | ₹17.46 | ₹19.33 | -0.62% | |
| ₹17.85 | ₹20.97 | ₹16.75 | ₹18.88 | +5.77% | |
| ₹18.25 | ₹19.50 | ₹17.50 | ₹17.90 | -1.92% | |
| ₹19.58 | ₹20.70 | ₹17.50 | ₹18.02 | -7.97% | |
| ₹21.00 | ₹23.77 | ₹19.14 | ₹19.39 | -7.67% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Veerhealth Care Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Veerhealth Care Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of VEERHEALTH across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Revenue Growth (198.22%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (25.05% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Conservative Debt Levels (D/E: 0.20)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (2.97%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (7.21%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (3.76%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Premium Valuation Risk (P/E: 121.00x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-470.00%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Earnings Growth (4.15% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-10.21 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Veerhealth Care Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Veerhealth Care Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Veerhealth Care LtdVeerhealth Care...Selected✓ VEERHEALTH • 511523 | 29.2/100 | ₹43.72₹44 | ₹81.07₹81.07 | 121.00Average 121.0 Average | 2.97%Poor 2.97% Poor | 7.21%Poor 7.21% Poor | 0.20Excellent 0.2 Excellent | 12.01%Good 12.01% Good | 25.05%Excellent 25.05% Excellent | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
Veerhealth Care Ltd PE Ratio History
Historical price-to-earnings ratio for VEERHEALTH — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.21 | ₹19.52 | 93x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Veerhealth Care Ltd Quarterly Performance
Latest quarterly metrics for VEERHEALTH — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
198.22%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-470.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
25.05%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
12.01%
Compounded annual net profit growth over 5 years
Veerhealth Care Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for VEERHEALTH — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Veerhealth Care Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Veerhealth Care Ltd (VEERHEALTH) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Veerhealth Care Ltd
About VEERHEALTH (Veerhealth Care Ltd)
Veerhealth Care Ltd is a dynamic pharmaceutical company deeply rooted in the principles of Ayurveda, dedicated to crafting holistic health and wellness solutions. With a focus on b...lending traditional knowledge with modern scientific advancements, Veerhealth develops, manufactures, and distributes a diverse portfolio of products designed to enhance overall well-being. Committed to quality and efficacy, the company meticulously sources its ingredients and adheres to stringent manufacturing practices, ensuring that each product meets the highest standards of purity and potency. Veerhealth's comprehensive approach aims to provide consumers with natural and effective alternatives for their health and beauty needs. The company's extensive product line encompasses a wide range of personal care and therapeutic solutions, all inspired by the ancient wisdom of Ayurveda. From revitalizing skincare formulations enriched with herbal extracts to nourishing hair care products that promote healthy growth and shine, Veerhealth offers a holistic approach to beauty and self-care. Their selection also includes Ayurvedic wellness products formulated to address various health concerns, such as digestive issues, joint pain, and stress management. Veerhealth further extends its reach through a variety of oral hygiene, grooming, and complementary product lines, offering a complete spectrum of offerings. Veerhealth Care Ltd places a strong emphasis on ethical and sustainable business practices. The company is committed to responsible sourcing, environmentally friendly manufacturing processes, and fair trade relationships with its suppliers. By prioritizing sustainability and social responsibility, Veerhealth aims to create a positive impact on both the environment and the communities it serves. Through its commitment to quality, innovation, and ethical conduct, Veerhealth Care Ltd aspires to be a trusted name in the pharmaceutical industry, empowering individuals to embrace a healthier and more balanced lifestyle through the power of Ayurveda.
Company Details
Key Leadership
Latest News
VEERHEALTH Share Price: Frequently Asked Questions
What is the current share price of Veerhealth Care Ltd?
Veerhealth Care Ltd (VEERHEALTH) trades at ₹43.72 on NSE and BSE. Market cap ₹81.07 (Cr). Educational data only.
What is the P/E ratio of Veerhealth Care Ltd?
Veerhealth Care Ltd has a P/E of 121.00x vs industry average 34.89x.
What is the Bull Run score for Veerhealth Care Ltd?
Veerhealth Care Ltd has a Bull Run score of 29.2/100 based on 25+ financial parameters.
Does Veerhealth Care Ltd pay dividends?
Veerhealth Care Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Veerhealth Care Ltd?
Veerhealth Care Ltd has ROE of 2.97%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Veerhealth Care Ltd?
Veerhealth Care Ltd has debt-to-equity of 0.20.
Is Veerhealth Care Ltd a good investment?
Bull Run gives Veerhealth Care Ltd a score of 29.2/100. This is not investment advice — consult a SEBI-registered advisor.